Soleno Therapeutics (SLNO) Capital Expenditures (2013 - 2026)
Soleno Therapeutics (SLNO) reported Capital Expenditures of $40000.0 for Q1 2026, down 31.03% on a QoQ basis from $58000.0 in Q4 2025.
Soleno Therapeutics (SLNO) has 12 years of Capital Expenditures data on file, last reported at $40000.0 in Q1 2026.
- Quarterly Capital Expenditures changed N/A year-over-year to $40000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113000.0 (down 45.41% YoY) and the FY2025 annual result came in at $73000.0, down 66.51% from the prior year.
- Capital Expenditures retreated to $40000.0 in Q1 2026 per SLNO's latest filing, from $58000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $191000.0 in Q3 2024 and bottomed at $1000.0 in Q3 2025.
- The 4-year median for Capital Expenditures is $11000.0 (2024), against an average of $37444.4.
- Peak annual rise in Capital Expenditures reached 625.0% in 2025, while the deepest fall reached 99.48% in 2025.
- Tracing SLNO's Capital Expenditures over 4 years: stood at $6000.0 in 2022, then jumped by 33.33% to $8000.0 in 2024, then soared by 625.0% to $58000.0 in 2025, then slumped by 31.03% to $40000.0 in 2026.
- Per Business Quant, the three latest SLNO Capital Expenditures figures stand at $40000.0 (Q1 2026), $58000.0 (Q4 2025), and $1000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40,000.00 |
| Mar 31, 2026 | 40,000.00 |
| Dec 31, 2025 | 58,000.00 |
| Dec 31, 2025 | 58,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | -2,000.00 |
| Dec 31, 2020 | -2,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Mar 31, 2019 | 10,000.00 |
| Mar 31, 2019 | 10,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 5,000.00 |
| Sep 30, 2018 | 5,000.00 |
| Dec 31, 2017 | 569,000.00 |
| Dec 31, 2017 | 569,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Jun 30, 2017 | -1,000.00 |
| Jun 30, 2017 | -1,000.00 |
| Mar 31, 2017 | 4,000.00 |
| Mar 31, 2017 | 4,000.00 |
| Dec 31, 2016 | -7,205.00 |
| Dec 31, 2016 | -7,205.00 |
| Sep 30, 2016 | 2,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 19,000.00 |
| Mar 31, 2016 | 19,000.00 |
| Dec 31, 2015 | -244,223.00 |
| Dec 31, 2015 | -244,223.00 |
| Sep 30, 2015 | -150,000.00 |
| Sep 30, 2015 | -150,000.00 |
| Jun 30, 2015 | 449,000.00 |
| Jun 30, 2015 | 449,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Dec 31, 2013 | 274.00 |
| Dec 31, 2013 | 274.00 |